PDL BioPharma up for sale

PDL BioPharma Inc. (PDL) is actively seeking offers for the sale of the company as a whole or of its key assets following a review of its strategic alternatives.

In conjunction with the announcement of the potential sale on Monday, CEO and director Mark McDade also stepped down immediately. The company’s board elected former chairperson of the board L. Patrick Gage as interim CEO and Karen A. Dawes as the new chairperson of the board.

The company has said it is relocating from Fremont to Redwood City this fall.

Just Posted

SFUSD going back to basics with school lunches made from scratch

Upgraded culinary center could serve as model for expanded in-house food production.

Sliding doors could open up more space on Muni buses

A simple engineering change could soon make Muni’s 900 buses roomier across… Continue reading

City struggles to find alternatives for inmates in seismically unsafe jail

Mayor London Breed has given City Hall a deadline to close down… Continue reading

E-scooter company Skip announces layoffs after losing SF permit

San Francisco-based e-scooter company Skip this week announced pending layoffs for roughly… Continue reading

Juul suspends sale of flavored e-cigarettes

San Francisco-based e-cigarette maker Juul Labs announced Thursday that it is suspending… Continue reading

Most Read